Takeda Pharmaceutical Company Limited (4502.T)
JPY 4419.0
(1.08%)
JPY 4419.0
(1.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4385.95 Billion JPY | 13.96% |
| 2022 | 3848.81 Billion JPY | 10.1% |
| 2021 | 3495.71 Billion JPY | -4.73% |
| 2020 | 3669.14 Billion JPY | -17.65% |
| 2019 | 4455.69 Billion JPY | -11.75% |
| 2018 | 5048.85 Billion JPY | 630.51% |
| 2017 | 691.14 Billion JPY | -16.27% |
| 2016 | 825.43 Billion JPY | 160.56% |
| 2015 | 316.79 Billion JPY | 310.18% |
| 2014 | 77.23 Billion JPY | -60.18% |
| 2013 | 193.93 Billion JPY | -27.69% |
| 2012 | 268.2 Billion JPY | 147.61% |
| 2011 | 108.31 Billion JPY | 153.78% |
| 2010 | -201.41 Billion JPY | 18.7% |
| 2009 | -247.73 Billion JPY | -18.1% |
| 2008 | -209.76 Billion JPY | 86.95% |
| 2007 | -1607.4 Billion JPY | 1.75% |
| 2006 | -1636.07 Billion JPY | -1.39% |
| 2005 | -1613.65 Billion JPY | -29.52% |
| 2004 | -1245.82 Billion JPY | -17.37% |
| 2003 | -1061.44 Billion JPY | -5.05% |
| 2002 | -1010.4 Billion JPY | -36.29% |
| 2001 | -741.37 Billion JPY | -19.91% |
| 2000 | -618.27 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 4676.71 Billion JPY | 6.63% |
| 2024 Q2 | 4192.17 Billion JPY | -10.36% |
| 2023 Q1 | 4430.73 Billion JPY | 15.12% |
| 2023 Q4 | 4385.95 Billion JPY | 0.23% |
| 2023 Q2 | 4361.15 Billion JPY | -1.57% |
| 2023 Q3 | 4375.8 Billion JPY | 0.34% |
| 2023 FY | 4385.95 Billion JPY | 13.96% |
| 2022 Q1 | 3956.26 Billion JPY | 13.17% |
| 2022 Q4 | 3848.81 Billion JPY | 6.86% |
| 2022 Q3 | 3601.76 Billion JPY | -8.55% |
| 2022 Q2 | 3938.5 Billion JPY | -0.45% |
| 2022 FY | 3848.81 Billion JPY | 10.1% |
| 2021 Q4 | 3495.71 Billion JPY | -3.71% |
| 2021 Q2 | 3623.47 Billion JPY | -3.4% |
| 2021 Q1 | 3750.94 Billion JPY | 2.23% |
| 2021 FY | 3495.71 Billion JPY | -4.73% |
| 2021 Q3 | 3630.53 Billion JPY | 0.19% |
| 2020 FY | 3669.14 Billion JPY | -17.65% |
| 2020 Q1 | 4485.17 Billion JPY | 0.66% |
| 2020 Q2 | 4277.16 Billion JPY | -4.64% |
| 2020 Q3 | 4133.41 Billion JPY | -3.36% |
| 2020 Q4 | 3669.14 Billion JPY | -11.23% |
| 2019 FY | 4455.69 Billion JPY | -11.75% |
| 2019 Q3 | 4653.47 Billion JPY | 3.85% |
| 2019 Q2 | 4481.09 Billion JPY | -11.42% |
| 2019 Q1 | 5058.9 Billion JPY | 0.2% |
| 2019 Q4 | 4455.69 Billion JPY | -4.25% |
| 2018 Q4 | 5048.85 Billion JPY | 124.3% |
| 2018 Q3 | 2250.91 Billion JPY | 229.34% |
| 2018 Q2 | 683.45 Billion JPY | -10.48% |
| 2018 Q1 | 763.49 Billion JPY | 10.47% |
| 2018 FY | 5048.85 Billion JPY | 630.51% |
| 2017 Q1 | 712.54 Billion JPY | -13.68% |
| 2017 FY | 691.14 Billion JPY | -16.27% |
| 2017 Q4 | 691.14 Billion JPY | -1.01% |
| 2017 Q3 | 698.21 Billion JPY | -1.17% |
| 2017 Q2 | 706.46 Billion JPY | -0.85% |
| 2016 Q2 | 332.12 Billion JPY | -10.9% |
| 2016 Q4 | 825.43 Billion JPY | 98.07% |
| 2016 Q3 | 416.73 Billion JPY | 25.48% |
| 2016 Q1 | 372.73 Billion JPY | 17.66% |
| 2016 FY | 825.43 Billion JPY | 160.56% |
| 2015 FY | 316.79 Billion JPY | 310.18% |
| 2015 Q4 | 316.79 Billion JPY | 87.27% |
| 2015 Q3 | 169.16 Billion JPY | 40.1% |
| 2015 Q2 | 120.75 Billion JPY | -22.97% |
| 2015 Q1 | 156.75 Billion JPY | 102.96% |
| 2014 Q3 | 131.36 Billion JPY | -33.89% |
| 2014 FY | 77.23 Billion JPY | -60.18% |
| 2014 Q1 | 233 Billion JPY | 20.14% |
| 2014 Q2 | 198.7 Billion JPY | -14.72% |
| 2014 Q4 | 77.23 Billion JPY | -41.21% |
| 2013 Q4 | 193.93 Billion JPY | -44.62% |
| 2013 FY | 193.93 Billion JPY | -27.69% |
| 2013 Q3 | 350.17 Billion JPY | -20.2% |
| 2013 Q2 | 438.83 Billion JPY | 59.71% |
| 2013 Q1 | 274.76 Billion JPY | 2.45% |
| 2012 FY | 268.2 Billion JPY | 147.61% |
| 2012 Q1 | 337.41 Billion JPY | 211.51% |
| 2012 Q4 | 268.2 Billion JPY | -4.09% |
| 2012 Q2 | 329.26 Billion JPY | -2.41% |
| 2012 Q3 | 279.63 Billion JPY | -15.07% |
| 2011 Q2 | 322.78 Billion JPY | 269.89% |
| 2011 FY | 108.31 Billion JPY | 153.78% |
| 2011 Q3 | 348.57 Billion JPY | 7.99% |
| 2011 Q1 | -189.99 Billion JPY | 5.67% |
| 2011 Q4 | 108.31 Billion JPY | -68.93% |
| 2010 Q4 | -201.41 Billion JPY | -5.98% |
| 2010 Q1 | -226.7 Billion JPY | 8.49% |
| 2010 Q2 | -218.99 Billion JPY | 3.4% |
| 2010 Q3 | -190.04 Billion JPY | 13.22% |
| 2010 FY | -201.41 Billion JPY | 18.7% |
| 2009 Q2 | -257.62 Billion JPY | 0.0% |
| 2009 FY | -247.73 Billion JPY | -18.1% |
| 2009 Q4 | -247.73 Billion JPY | 8.87% |
| 2009 Q3 | -271.85 Billion JPY | -5.52% |
| 2008 FY | -209.76 Billion JPY | 86.95% |
| 2008 Q3 | -218.86 Billion JPY | 0.0% |
| 2008 Q4 | -209.76 Billion JPY | 4.16% |
| 2007 FY | -1607.4 Billion JPY | 1.75% |
| 2006 FY | -1636.07 Billion JPY | -1.39% |
| 2005 FY | -1613.65 Billion JPY | -29.52% |
| 2004 FY | -1245.82 Billion JPY | -17.37% |
| 2003 FY | -1061.44 Billion JPY | -5.05% |
| 2002 FY | -1010.4 Billion JPY | -36.29% |
| 2001 FY | -741.37 Billion JPY | -19.91% |
| 2000 FY | -618.27 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | -357936.898% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | -1025.073% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 1365.897% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 123158.552% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 10504.099% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 7234.646% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 4578.569% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | 657664.018% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 8563.658% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 13422.657% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | -57594.712% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | -56267.459% |
| Tsumura & Co. | 1.61 Billion JPY | -271475.975% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 10031.957% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 12836.162% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | -2439.548% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | -16373.678% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | -15033.489% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | -62023.966% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -622904.545% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | -73096.796% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 67400.097% |
| MedRx Co., Ltd | -1.72 Billion JPY | 255097.209% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 50418.019% |
| Solasia Pharma K.K. | -668 Million JPY | 656679.641% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | 298274.021% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 60570.867% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | -7659.725% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 148235.369% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 4555.955% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 39508.0% |